Braun Stacey Associates’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-44,672
| Closed | -$21.7M | – | 126 |
|
|
2025
Q1 | $21.7M | Sell |
44,672
-778
| -2% | -$377K | 0.89% | 51 |
|
|
2024
Q4 | $18.3M | Sell |
45,450
-6,047
| -12% | -$2.44M | 0.68% | 61 |
|
|
2024
Q3 | $24M | Sell |
51,497
-5,361
| -9% | -$2.49M | 0.91% | 42 |
|
|
2024
Q2 | $26.7M | Sell |
56,858
-2,664
| -4% | -$1.25M | 1.03% | 31 |
|
|
2024
Q1 | $24.9M | Sell |
59,522
-803
| -1% | -$336K | 0.98% | 38 |
|
|
2023
Q4 | $24.5M | Sell |
60,325
-557
| -0.9% | -$227K | 1.1% | 28 |
|
|
2023
Q3 | $21.2M | Sell |
60,882
-173
| -0.3% | -$60.2K | 1.03% | 37 |
|
|
2023
Q2 | $21.5M | Sell |
61,055
-35,615
| -37% | -$12.5M | 1% | 36 |
|
|
2023
Q1 | $30.5M | Buy |
+96,670
| New | +$30.5M | 0.8% | 61 |
|
|
2020
Q4 | – | Sell |
-65,312
| Closed | -$17.8M | – | 139 |
|
|
2020
Q3 | $17.8M | Sell |
65,312
-670
| -1% | -$182K | 0.95% | 36 |
|
|
2020
Q2 | $19.2M | Buy |
65,982
+7,099
| +12% | +$2.06M | 1.1% | 19 |
|
|
2020
Q1 | $14M | Buy |
+58,883
| New | +$14M | 1.07% | 34 |
|